J&J Unit Escapes FCA Case Over Alleged Procrit Kickbacks

Law360, New York (August 14, 2012, 1:25 PM EDT) -- A biotechnology unit of Johnson & Johnson on Monday dispensed with the remnants of a False Claims Act case alleging kickbacks to doctors who prescribed anemia drug Procrit after the relator conceded she lacked evidence to support the few allegations left intact after years of litigation.

U.S. District Judge Rya W. Zobel two years ago sharply limited the scope of the case, pointing out that account specialist Mark Duxbury had been fired in 1998 and that the complaint wasn’t filed until 2003. Because the False Claims...
To view the full article, register now.